Benjamin F. Edwards & Company’s Organon & Co OGN Stock Holding History

Benjamin F. Edwards & Company’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$171K	Buy	8,258 +60	+0.7%	+$1.19K	﹤0.01%	955
2024 Q1	$154K	Sell	8,198 -505	-6%	-$8.67K	﹤0.01%	982
2023 Q4	$126K	Sell	8,703 -1,664	-16%	-$22.6K	﹤0.01%	1007
2023 Q3	$180K	Buy	10,367 +1,724	+20%	+$35.9K	0.01%	763
2023 Q2	$180K	Sell	8,643 -1,761	-17%	-$38.3K	0.01%	765
2023 Q1	$245K	Sell	10,404 -13,683	-57%	-$367K	0.01%	655
2022 Q4	$673K	Buy	24,087 +217	+0.9%	+$5.55K	0.03%	403
2022 Q3	$559K	Buy	23,870 +302	+1%	+$9.12K	0.03%	412
2022 Q2	$795K	Sell	23,568 -572	-2%	-$20K	0.04%	372
2022 Q1	$843K	Buy	24,140 +4,149	+21%	+$142K	0.04%	374
2021 Q4	$609K	Buy	19,991 +18,197	+1,014%	+$593K	0.03%	434
2021 Q3	$59K	Sell	1,794 -1,145	-39%	-$36.6K	﹤0.01%	986
2021 Q2	$89K	Buy	+2,939	New	+$96.7K	﹤0.01%	874

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

SPC

Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Benjamin F. Edwards & Company's OGN Position: Q2 2024 in Review

Benjamin F. Edwards & Company increased its Organon & Co (OGN) stake by 0.73% in Q2 2024, buying an estimated $1.19K and bringing the position to 8,258 shares worth $171K. The position accounts for ﹤0.01% of the portfolio, ranked #955.

Benjamin F. Edwards & Company first reported a position in OGN in Q2 2021 and has held it in 13 quarters since. The position peaked at $843K in Q1 2022. 724 funds tracked by Wall St. Rank hold OGN as of Q2 2024.

Benjamin F. Edwards & Company held 8,258 shares of Organon & Co worth $171K as of Q2 2024.
Benjamin F. Edwards & Company bought 60 Organon & Co shares in Q2 2024, an estimated $1.19K.
Organon & Co made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #955 holding.
Benjamin F. Edwards & Company first reported a position in Organon & Co in Q2 2021 and has held it in 13 quarters since.
Benjamin F. Edwards & Company's Organon & Co position peaked at $843K in Q1 2022.
724 funds tracked by Wall St. Rank held Organon & Co as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.